Status:
COMPLETED
Acupoint Stimulation Improves Fatigue and Sleep Quality in Patients With Postdialysis
Lead Sponsor:
Taipei Veterans General Hospital, Taiwan
Conditions:
Hemodialysis
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Hemodialysis is a necessary treatment to prolong the lives of patients with end-stage kidney disease. However, long-term dialysis can lead to fatigue and decreased sleep quality. Acupoint stimulation ...
Detailed Description
Hemodialysis is a necessary treatment to prolong the lives of patients with end-stage kidney disease. However, long-term dialysis can lead to fatigue and decreased sleep quality. Acupoint stimulation ...
Eligibility Criteria
Inclusion
- Adults aged 20 years and above.
- Diagnosed with end-stage kidney disease and receiving regular outpatient hemodialysis three times a week for at least three months.
- Conscious and capable of communication in Mandarin or Taiwanese (Hokkien).
- Willing to participate in this study and have signed the informed consent form.
Exclusion
- Presence of skin lesions or infectious wounds at the acupoint locations.
- Taking immunosuppressive medication.
- Photosensitivity or sensitivity to light.
- Individuals with implanted cardiac pacemakers.
- Patients using sleep medication.
Key Trial Info
Start Date :
August 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 21 2023
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT06028685
Start Date
August 12 2022
End Date
February 21 2023
Last Update
September 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Veterans General Hospital
Taipei, Taiwan, 11217